(Q41896190)

13 October 2017

title

Lovastatin ameliorates the development of glomerulosclerosis and uremia in experimental nephrotic syndrome (English)

1 reference

13 October 2017

1 reference

1 reference

Harris KP

1

1 reference

13 October 2017

Purkerson ML

series ordinal

2

1 reference

13 October 2017

Yates J

series ordinal

3

1 reference

13 October 2017

Klahr S

series ordinal

4

1 reference

13 October 2017

publication date

1 January 1990

1 reference

American Journal of Kidney Diseases

13 October 2017

published in

1 reference

13 October 2017

volume

15

1 reference

13 October 2017

issue

1

1 reference

13 October 2017

page(s)

16-23

1 reference

The progression of renal disease

13 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Lipid nephrotoxicity in chronic progressive glomerular and tubulo-interstitial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Focal and segmental glomerulosclerosis: analogies to atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Aortic and renal lesions in hypercholesterolemic adult, male, virgin sprague-dawley rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Glomerular disease in hypercholesterolemia guinea pigs: A pathogenetic study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Exacerbation of chronic aminonucleoside nephrosis by dietary cholesterol supplementation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Lipid abnormalities in uremia, dialysis, and transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Hyperlipoproteinemia in nephrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

The enhancement of aminonucleoside nephrosis by the co-administration of protamine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

[A simple colorimetric method of inulin determination in renal clearance studies on metabolically normal subjects and diabetics]

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

The effects of mevinolin on serum cholesterol levels of rabbits with endogenous hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Cholesterol-lowering effect of mevinolin, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme a reductase, in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Effect of mevinolin on cholesterol metabolism in obese and lean Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Lovastatin therapy in nephrotic hyperlipidemia: effects on lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

EFFECTS OF SIMVASTATIN AND CHOLESTYRAMINE ON LIPOPROTEIN PROFILE IN HYPERLIPIDAEMIA OF NEPHROTIC SYNDROME

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

"Intact nephrons" as the primary origin of proteinuria in chronic renal disease. Study in the rat model of subtotal nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Mechanisms of the puromycin-induced defects in the transglomerular passage of water and macromolecules

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Mesangial function and glomerular sclerosis in rats after unilateral nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

Secretory products of macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980587-7

7 January 2021

10.1016/S0272-6386(12)80587-7

Identifiers

DOI

1 reference

13 October 2017

1 reference